Your browser doesn't support javascript.
loading
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Hampras, Shalaka S; Sucheston-Campbell, Lara E; Cannioto, Rikki; Chang-Claude, Jenny; Modugno, Francesmary; Dörk, Thilo; Hillemanns, Peter; Preus, Leah; Knutson, Keith L; Wallace, Paul K; Hong, Chi-Chen; Friel, Grace; Davis, Warren; Nesline, Mary; Pearce, Celeste L; Kelemen, Linda E; Goodman, Marc T; Bandera, Elisa V; Terry, Kathryn L; Schoof, Nils; Eng, Kevin H; Clay, Alyssa; Singh, Prashant K; Joseph, Janine M; Aben, Katja K H; Anton-Culver, Hoda; Antonenkova, Natalia; Baker, Helen; Bean, Yukie; Beckmann, Matthias W; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A; Brooks-Wilson, Angela; Bruinsma, Fiona; Butzow, Ralf; Campbell, Ian G; Carty, Karen; Cook, Linda S; Cramer, Daniel W; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Dennis, Joe; Despierre, Evelyn; Dicks, Ed; Doherty, Jennifer A; du Bois, Andreas; Dürst, Matthias; Easton, Doug.
Afiliação
  • Hampras SS; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Sucheston-Campbell LE; College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
  • Cannioto R; Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Chang-Claude J; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Modugno F; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.
  • Dörk T; Department of Epidemiology and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Hillemanns P; Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
  • Preus L; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Knutson KL; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
  • Wallace PK; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Hong CC; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
  • Friel G; Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Davis W; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Nesline M; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Pearce CL; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Kelemen LE; Center for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Goodman MT; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
  • Bandera EV; Alberta Health Services-Cancer Care, Department of Population Health Research, Calgary, Alberta, Canada.
  • Terry KL; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Schoof N; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Eng KH; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Clay A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Singh PK; Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Joseph JM; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Aben KK; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Anton-Culver H; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
  • Antonenkova N; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Baker H; Department of Epidemiology and School of Medicine, University of California Irvine, Irvine, California, USA.
  • Bean Y; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus.
  • Beckmann MW; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Bisogna M; Department of Obstetrics & Gynecology and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Bjorge L; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Bogdanova N; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Brinton LA; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • Brooks-Wilson A; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Bruinsma F; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Butzow R; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Campbell IG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
  • Carty K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Cook LS; Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Australia.
  • Cramer DW; Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.
  • Cybulski C; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
  • Dansonka-Mieszkowska A; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Dennis J; International Hereditary Cancer Center, Department of Genetics and Pathology, Clinic of Opthalmology, Pomeranian Medical University, Szczecin, Poland.
  • Despierre E; Department of Pathology and Labolatory Diagnostic, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Dicks E; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Doherty JA; Division of Gynecological Oncology, Department of Oncology, University Hospitals Leuven, Belgium.
  • du Bois A; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Dürst M; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Easton D; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany.
Oncotarget ; 7(43): 69097-69110, 2016 10 25.
Article em En | MEDLINE | ID: mdl-27533245
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Serina-Treonina Quinases / Receptores de Fatores de Crescimento Transformadores beta / Adenocarcinoma de Células Claras / Neoplasias Epiteliais e Glandulares / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Serina-Treonina Quinases / Receptores de Fatores de Crescimento Transformadores beta / Adenocarcinoma de Células Claras / Neoplasias Epiteliais e Glandulares / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article